Metabolic syndrome predicts cardiovascular (CV) mortality. Most criteria use predefi ned thresholds and perform variably depending on the characteristics of the cohort under examination. Aims/Methods: (1) We computed a continuous metabolic syndrome standardized score (zMS) for hypertension, obesity, dyslipidaemia, fasting insulin level, and glucose intolerance, and tested whether zMS predicts 8.8yr CV mortality in 11,790 middle-aged Caucasian European men and women. (2) We subsequently explored the independent and combined effects of physical activity energy expenditure (PAEE) and cardiorespiratory fi tness (VO 2max ) on zMS in a sub-sample of the original cohort (n=867). At 3-month intervals, 4 measures of objectively measured PAEE (heart-rate fl ex) and VO 2max were used to correct differences in exposure measurement error; a type of bias that is usually ignored in comparison studies of this kind. Aims: Our purpose was to study determinants involved in the improved glycaemic control and insulin sensitivity, resulting from a 2-year exercise and dietary intervention in middle-aged IGT subjects. Methods: In all, 22 persons with IGT from the intervention group of The Finnish Diabetes Prevention Study volunteered to give samples from the M. vastus lateralis. Based on their response to the intervention, they were divided into two groups: 1) persons whose body weight decreased, and 2) those whose body weight increased or did not change. Changes in glucose tolerance, oxidative capacity, dietary intake and in the expression of cytokines were studied before and after the 2-year intervention. Results: The glycaemic control, insulin sensitivity and oxidative capacity improved only in the group with decreased body weight. Expression of mRNAs for TNF-α and INF-γ tended to decrease in the group with decreased body weight, whereas they increased in those with increased or unchanged body weight. Conclusions: The glycaemic control improved only if IGT subjects reduced their weight and improved their oxidative capacity. This improvement may lead to enhanced insulin sensitivity and to a reduction of cytokines in skeletal muscle. Aim: The purpose of this study was to evaluate and to compare the effect of a 4-months' endurance training program on isoproterenol-(β-receptor agonist) and atrial natriuretic peptide (ANP)-induced in situ lipolysis and vasodilation in subcutaneous adipose tissue (SCAT) of overweight men. Methods: Ten overweight men aged 25.6 ± 1.4 years with a mean BMI of 27.7 ± 0.2 kg/m 2 , practiced aerobic exercise 5 days/wk during 4 months. Before and after the training period, SCAT lipolytic and blood fl ow responses were investigated in situ during 60-min perfusions of 1 µmol/l isoproterenol and 10 µmol/l ANP through microdialysis probes. Plasma metabolic and physical fi tness variables were measured as well. Results: Endurance training has signifi cantly increased VO 2max and lowered plasma insulin, glucose, LDL-C and the respiratory quotient. The lipid-mobilizing effect of ANP was markedly enhanced (by 191%, p=0.04) after training, as well as that of isoproterenol (by 145%, p=0.04). ANP and isoproterenol-induced vasodilation increased after training (p<0.001). Training signifi cantly lowered the resting extracellular glycerol levels in SCAT (p<0.001). Resting adipose tissue blood fl ow was not modifi ed by training. Conclusions: Endurance training improves effi ciently ANP and β-AR pathway sensitivity both on fat cells and on vessels in the SCAT of overweight men.
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T7c:O1-002 INSULIN AND ADIPOSE TISSUE REESTERIFICATION IN TYPE 2 DIABETES
Simonsen Lene, Enevoldsen Lotte Hahn, Bülow Jens Department of Physiology, Bispebjerg Hospital, Copenhagen, Denmark Aims: To study local adipose tissue lipolysis and fatty acid mobilization during hyperinsulinaemic euglycaemic clamp and exercise in normal healthy subjects and type 2 diabetic patients. Methods: 6 normal-weight subjects (Nor) and 7 obese type 2 diabetic patients (DM) were studied. Abdominal, subcutaneous adipose tissue metabolism was measured by the Fick's principle (1) . The experiments were performed during 1 h rest in the postabsorptive state. Thereafter, a euglycemic insulin clamp was established. When steady-state glucose infusion rate was reached (after about 2 hours), the subjects exercised for 1 hour at 50% of their peak oxygen uptake. The glucose infusion rate was increased to keep the arterial glucose level constant. 
Conclusion:
The insulin clamp induced about 50% reduction in lipolysis in both study groups. However, the adipose tissue fatty acid output decreased to nearly zero in the patient group, indicating that the intracellular re-esterifi cation of fatty acids was more than 10 fold increased. Exercise did not change this phenomenon. This review addresses the metabolic responses to physical exercise and relates the responses to health benefi ts of exercise. The two main questions to be answered are: (1) what are the differences in metabolic responses between (a) low-to-moderate vs. high-intensity exercise and (b) aerobic vs. strength training? (2) are these differences related to health? Aerobic (endurance) training leads to increased capillary density, increased muscle lipoprotein lipase activity, insulin sensitivity and increased GLUT-4 transport protein content. Even quite moderate intensity (3-6 METs) physical activity may lead to these changes, at least if the activity is repeated on an almost daily basis. Some health benefi ts (e.g. blood lipoprotein profi les) may require more vigorous training. Depending on the program design (load and number of repetitions), resistance exercise may enhance strength, power and/or local muscular endurance.
Muscle hypertrophy leads to decreased capillary density (capillaries/area of tissue), but capillary/fi ber ratio increases. Increased muscle crosssectional area is associated with improved insulin sensitivity. Moreover, resistance training lowers diastolic blood pressure by 4%, but the effects on blood lipoproteins are less clear. In conclusion, low-to-moderate-intensity aerobic activity leads to improved muscle metabolic fi tness and health. The present physical activity recommendation (30 min/day moderate) seems adequate to offset most of the health risks associated with total inactivity, but additional health benefi ts will be gained by increasing the amount and/or intensity. For most of the last century, researchers have searched for a musclecontraction-induced factor, which mediates some of the exercise effects in other tissues, such as the liver and the adipose tissue. It has been called the "work stimulus", the "work factor" or the "exercise factor". In our search for such a factor, we found a cytokine, IL-6, which is produced by contracting muscles and released into the blood. We have demonstrated that IL-6 has many biological roles such as: (1) activation/inhibition of metabolic genes, (2) induction of lipolysis, (3) inhibition of insulin resistance and (4) suppression of TNF-production. The IL-6 gene is rapidly activated during exercise and the activation of this gene is further enhanced when muscle glycogen content is low. In addition, carbohydrate supplementation during exercise has been shown to inhibit the release of IL-6 from contracting muscle. Thus, it is suggested that muscle-derived IL-6 fulfi ls the criteria of an exercise factor and that such classes of cytokines should be named "myokines".
